Variation in the volume-outcome relationship after rectal cancer surgery in the United States: Retrospective study with implications for regionalization.

Autor: Becerra AZ; Department of Surgery, Rush University Medical Center, Chicago, IL. Electronic address: Adan_becerra@rush.edu., Aquina CT; Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH., Grunvald MW; Department of Surgery, Rush University Medical Center, Chicago, IL., Underhill JM; Department of Surgery, Rush University Medical Center, Chicago, IL., Bhama AR; Department of Surgery, Rush University Medical Center, Chicago, IL., Hayden DM; Department of Surgery, Rush University Medical Center, Chicago, IL. Electronic address: https://twitter.com/dmhayden21.
Jazyk: angličtina
Zdroj: Surgery [Surgery] 2022 Oct; Vol. 172 (4), pp. 1041-1047. Date of Electronic Publication: 2021 Dec 25.
DOI: 10.1016/j.surg.2021.11.028
Abstrakt: Background: Previous studies have demonstrated improved outcomes for patients with rectal cancer treated at higher-volume hospitals. However, little is known whether heterogeneity in this effect exists. The objective was to test whether the effect of increased annual rectal cancer resection volume on outcomes is consistent across all hospitals treating rectal cancer.
Methods: Adult stage I to III patients who underwent surgical resection for rectal adenocarcinoma from 2004 to 2016 were identified in the National Cancer Database.
Results: We included 120,522 patients treated at 763 hospitals in this retrospective cohort study. Higher volume was linearly and incrementally related to outcomes in unadjusted analyses. In adjusted models, for an average patient at the average hospital, the effect of increasing the annual caseload of rectal cancer resections by 20 resections per year was associated with 8%, (hazard ratio = 0.92, 95% confidence interval = 0.87, 0.97), 18% (odds ratio = 0.82, 95% confidence interval = 0.70, 0.98), and 16% (odds ratio = 0.84, 95% confidence interval = 0.73, 0.95) relative reductions in 5-year overall survival, 30-, and 90-day mortality, respectively, and with a 19% (odds ratio = 1.19, 95% confidence interval = 1.04, 1.36) relative increase in the rate of neoadjuvant chemoradiation. These effects varied by individual hospitals such that 39% of hospitals do not see any benefit in 5-year overall survival associated with higher volumes. Increased volume was associated with lower positive circumferential resection margin rates at 19% of the hospitals.
Conclusion: This study confirms that higher-volume hospitals have improved outcomes after rectal cancer surgery. However, there exists significant variation in these effects induced by individual within-hospital effects. Regionalization policies may need to be flexible in identifying the hospitals that would achieve enhanced benefits from treating a larger volume of patients.
(Copyright © 2021 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: